Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03034263
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
MOI | (7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A- HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2- E]ISOQUINOLINE-7,9-DIOL | H,L | 1Q0Y | 0.74 | |
AEH | 4-(2-aminoethyl)-2-ethylphenol | A | 3BUG | 0.74 | |
DAH | 3,4-DIHYDROXYPHENYLALANINE | A,B | 1RNR | 0.74 | |
DAH | 3,4-DIHYDROXYPHENYLALANINE | A | 6PAH | 0.74 | |
DAH | 3,4-DIHYDROXYPHENYLALANINE | A,B | 1IVV | 0.74 | |
ECS | 2,3,17BETA-TRIHYDROXY-1,3,5(10)- ESTRATRIENE | A,B,C,D | 2BW7 | 0.71 | |
AEJ | (1S)-1-{4-[(9AR)-OCTAHYDRO-2H-PYRIDO[1,2- A]PYRAZIN-2-YL]PHENYL}-2-PHENYL- 1,2,3,4-TETRAHYDROISOQUINOLIN-6- OL | A,B,C,D | 1XQC | 0.72 | |
AEF | 4-(2-aminoethyl)phenol | A | 3BRA | 0.71 | |
ALE | L-EPINEPHRINE | A | 3PAH | 0.78 | |
ALE | L-EPINEPHRINE | A | 2HKK | 0.78 | |
LNR | L-NOREPINEPHRINE | A,B | 2QEO | 0.74 | |
LNR | L-NOREPINEPHRINE | A | 3DYE | 0.74 | |
LNR | L-NOREPINEPHRINE | A | 4PAH | 0.74 | |
BPY | BIPHENYL-2,3-DIOL | A | 1KMY | 0.71 | |
BPY | BIPHENYL-2,3-DIOL | B | 1KW8 | 0.71 | |
BPY | BIPHENYL-2,3-DIOL | A | 2EI3 | 0.71 | |
BPY | BIPHENYL-2,3-DIOL | A | 1EIR | 0.71 | |
BPY | BIPHENYL-2,3-DIOL | B | 1KW6 | 0.71 | |
BPY | BIPHENYL-2,3-DIOL | B | 1KWC | 0.71 | |
BPY | BIPHENYL-2,3-DIOL | B | 1KW9 | 0.71 | |
ETC | (R,R)-5,11-CIS-DIETHYL-5,6,11,12- TETRAHYDROCHRYSENE-2,8-DIOL | A,B | 1L2I | 0.71 | |
ETC | (R,R)-5,11-CIS-DIETHYL-5,6,11,12- TETRAHYDROCHRYSENE-2,8-DIOL | A,B | 1L2J | 0.71 | |
AHT | 4-(2,5-DIAMINO-5-HYDROXY-PENTYL)- PHENOL | I,T | 1TMB | 0.72 | |
AED | 4-(2-aminoethyl)-2-cyclohexylphenol | A | 3BUH | 0.77 | |
3QC | (4R)-4-(3-HYDROXYPHENYL)-N,N,7,8- TETRAMETHYL-3,4-DIHYDROISOQUINOLINE- 2(1H)-CARBOXAMIDE | A,B | 2FME | 0.78 | |
AOE | N-BUTYL-11-[(7R,8R,9S,13S,14S,17S)- 3,17-DIHYDROXY-13-METHYL-7,8,9,11,12,13,14,15,16,17- DECAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN- 7-YL]-N-METHYLUNDECANAMIDE | A | 1HJ1 | 0.7 | |
AEG | 4-[(2R)-2-aminopropyl]phenol | A | 3BUF | 0.74 | |
BM4 | 3-[(3R)-3-ethyl-1-{9-[(3S)-3-ethyl- 3-(3-hydroxyphenyl)azepan-1-yl]nonyl}azepan- 3-yl]phenol | X | 2W6C | 0.74 | |
LDP | L-DOPAMINE | A,B | 2A3R | 0.79 | |
LDP | L-DOPAMINE | A | 5PAH | 0.79 | |
LDP | L-DOPAMINE | A,B | 2QMZ | 0.79 | |
LDP | L-DOPAMINE | A,B | 2VQ5 | 0.79 | |
D1N | NAPHTHALENE-1,2-DIOL | A | 2EI1 | 0.73 | |
BP7 | 1,1'-BIPHENYL-3,4-DIOL | A | 2EI0 | 0.71 | |
DPD | A,B | 1QIW | 0.72 | ||
DPD | A | 1QIV | 0.72 |